1.
Kara M, Alp G, Cinakli H. Real-World Outcomes of Baricitinib Monotherapy Versus csDMARD Combination Therapy in Rheumatoid Arthritis: A SingleCenter Retrospective Analysis of Efficacy, Safety, and Drug Retention. Archives of Rheumatology [Internet]. 2025 Sep. 1 [cited 2025 Oct. 3];40(3):279-87. Available from: http://anadolupsikiyatri.net/index.php/pub/article/view/1508